Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Lynx1 Capital Management LP STOK Stoke Therapeutics, Inc. 13G 6% 3y
Ares Investments Holdings LLC VINP Vinci Compass Investments Ltd. 13D 15.3% 3y
Hydra LLC TRML Tourmaline Bio, Inc. Common Stock 13G 5.9% 3y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D 13.7% 3y
Lawrence M. Blatt, Ph.D. ALGS Aligos Therapeutics, Inc. 13D 5.3% 3y
Cormorant Asset Management, LP HARP Harpoon Therapeutics, Inc. Common Stock 13G 9.9% 3y
Kent P. Dauten RPC Ridgepost Capital, Inc. 13G/A 15% 3y
Kirin Holdings Company, Limited THRN Thorne Healthtech, Inc. Common Stock 13G/A 0% 3y
Andrew E. Shapiro PFIN P&F Industries 13G 7.4% 3y
MAK CAPITAL ONE LLC AGYS Agilysys Inc 13D/A 15.3% 3y
Conestoga Capital Advisors, LLC DGII Digi International Inc 13G 10.5% 3y
David T. Lu CYT Cyteir Therapeutics, Inc. Common Stock 13G 6.1% 3y
JAT Capital Mgmt LP NXH Neighborhood Intelligence, Inc. 13D/A 9.6% 3y
BIOTECHNOLOGY VALUE FUND L P RPTX Repare Therapeutics Inc. Common Shares 13D 21.6% 3y
Flawless Management Inc. GASS StealthGas Inc. 13D/A 26.1% 3y
VALINOR MANAGEMENT, L.P. NEXT NextDecade Corp 13D/A 6.85% 3y
Corvina Holdings Limited GROV Grove Collaborative Holdings, Inc. 13D/A 21.1% 3y
Virgin Investments Limited SPCE Virgin Galactic Holdings, Inc 13D/A 8.4% 3y
EnCap Partners GP, LLC PR Permian Resources Corp 13G 15.04% 3y
EnCap Partners GP, LLC ESTE Earthstone Energy Inc. Class A Common Stock 13D/A 0% 3y
Argus Seller, LP NDAQ Nasdaq, Inc. 13D 14.84% 3y
Anson Funds Management LP NNDM Nano Dimension Ltd. 13D/A 8.7% 3y
Jeffrey Osher BEEP Mobile Infrastructure Corp 13D/A 62.6% 3y
Sherif Abdou, M.D. PIII P3 Health Partners Inc. 13D/A 9.3% 3y
Arturo R. Moreno CCO Clear Channel Outdoor Holdings, Inc. 13D/A 6.4% 3y
AK Jensen Investment Management Limited ASPI ASP Isotopes Inc. 13G 13.8% 3y
Satter Muneer A RNTX Rein Therapeutics, Inc. 13D/A 19.9% 3y
STILWELL JOSEPH SFBC Sound Financial Bancorp, Inc. 13D/A 15.4% 3y
AREX CAPITAL MASTER FUND, LP FRGI Fiesta Restaurant Group, Inc. 13D/A 0% 3y
Flawless Management Inc. IMPP Imperial Petroleum Inc./Marshall Islands 13D/A 29.3% 3y
Fairmount Funds Management LLC VRDN Viridian Therapeutics, Inc.\DE 13D/A 19.99% 3y
Alessandra T. Norcross FRBK Republic First Bancorp Inc 13D/A 7.6% 3y
Laurence E. Hirsch MDAI Spectral AI, Inc. 13G 5.74% 3y
Commodore Capital LP HARP Harpoon Therapeutics, Inc. Common Stock 13G 9.9% 3y
TortoiseEcofin Sponsor III LLC TRTL TortoiseEcofin Acquisition Corp. III 13G/A 28.4% 3y
Engine Capital, L.P. OFIX Orthofix Medical Inc. 13D 7.3% 3y
Horton Capital Partners Fund, LP OSS One Stop Systems, Inc. 13D 5.35% 3y
Access Industries Management, LLC APGE Apogee Therapeutics, Inc. 13G 5.22% 3y
ADAGE CAPITAL PARTNERS GP, L.L.C. NKTX Nkarta, Inc. 13G 7.54% 3y
Kent Lake Capital LLC VAPO Vapotherm, Inc. Common Stock 13G 5.2% 3y
F. Hurst Lin (“Lin”) AUGX Augmedix, Inc. Common Stock 13D/A 10.9% 3y
Board of Directors of MetLife, Inc., as an entity MET Metlife Inc 13D/A 16% 3y
WHITE MOUNTAINS INSURANCE GROUP LTD MAX MediaAlpha, Inc. 13D/A 48.7% 3y
Soleus Capital Master Fund, L.P. YARW Yarrow Bioscience, Inc. 13G 6.4% 3y
TPG GP A, LLC TPG TPG Inc. 13D 80.4% 3y
TPG GP A, LLC HOUS Anywhere Real Estate Inc. 13D/A 8.9% 3y
Nextech Crossover I GP S.a. r.l. AMAM Ambrx Biopharma, Inc. Common Stock 13G 5% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.66% 3y
Advance/Newhouse Partnership CHTR Charter Communications, Inc. 13D/A 12.4% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 11.78% 3y